Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 Oct;82(19):6492–6496. doi: 10.1073/pnas.82.19.6492

Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.

J D Groopman, P R Donahue, J Q Zhu, J S Chen, G N Wogan
PMCID: PMC390743  PMID: 3931076

Abstract

A high-affinity IgM monoclonal antibody specific for aflatoxins was covalently bound to Sepharose 4B and used as a preparative column to isolate aflatoxin derivatives from the urine of people and experimental animals who had been exposed to the carcinogen environmentally or under laboratory conditions. Aflatoxin levels were quantified by radioimmunoassay and high-performance liquid chromatography after elution from the affinity column. In studies on rats injected with [14C]aflatoxin B1, we identified the major aflatoxin-DNA adduct, 2,3-dihydro-2-(N7-guanyl)-3-hydroxy-aflatoxin B1 (AFB1-N7-Gua), and the oxidative metabolites M1 and P1 as the major aflatoxin species present in the urine. When this methodology was applied to human urine samples obtained from people from the Guangxi Province of China exposed to aflatoxin B1 through dietary contamination, the aflatoxin metabolites detected were also AFB1-N7-Gua and aflatoxins M1 and P1. Therefore, affinity chromatography using a monoclonal antibody represents a useful and rapid technique with which to isolate this carcinogen and its metabolites in biochemical epidemiology and for subsequent quantitative measurements, providing exposure information that can be used for risk assessment.

Full text

PDF
6492

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Autrup H., Bradley K. A., Shamsuddin A. K., Wakhisi J., Wasunna A. Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7'-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, Kenya. Carcinogenesis. 1983 Sep;4(9):1193–1195. doi: 10.1093/carcin/4.9.1193. [DOI] [PubMed] [Google Scholar]
  2. Campbell T. C., Caedo J. P., Jr, Bulatao-Jayme J., Salamat L., Engel R. W. Aflatoxin M1 in human urine. Nature. 1970 Jul 25;227(5256):403–404. doi: 10.1038/227403a0. [DOI] [PubMed] [Google Scholar]
  3. Groopman J. D., Haugen A., Goodrich G. R., Wogan G. N., Harris C. C. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies. Cancer Res. 1982 Aug;42(8):3120–3124. [PubMed] [Google Scholar]
  4. Groopman J. D., Trudel L. J., Donahue P. R., Marshak-Rothstein A., Wogan G. N. High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7728–7731. doi: 10.1073/pnas.81.24.7728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Haugen A., Groopman J. D., Hsu I. C., Goodrich G. R., Wogan G. N., Harris C. C. Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4124–4127. doi: 10.1073/pnas.78.7.4124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Moss E. J., Judah D. J., Przybylski M., Neal G. E. Some mass-spectral and n.m.r. analytical studies of a glutathione conjugate of aflatoxin B1. Biochem J. 1983 Jan 15;210(1):227–233. doi: 10.1042/bj2100227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Tsuboi S., Nakagawa T., Tomita M., Seo T., Ono H., Kawamura K., Iwamura N. Detection of aflatoxin B1 in serum samples of male Japanese subjects by radioimmunoassay and high-performance liquid chromatography. Cancer Res. 1984 Mar;44(3):1231–1234. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES